Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging–Alzheimer’s Association Research Framework

IMPORTANCE: A National Institute on Aging–Alzheimer’s Association (NIA-AA) workgroup recently published a research framework in which Alzheimer disease is defined by neuropathologic or biomarker evidence of β-amyloid plaques and tau tangles and not by clinical symptoms. OBJECTIVES: To estimate the s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Neurol
Autors principals: Jack, Clifford R., Therneau, Terry M., Weigand, Stephen D., Wiste, Heather J., Knopman, David S., Vemuri, Prashanthi, Lowe, Val J., Mielke, Michelle M., Roberts, Rosebud O., Machulda, Mary M., Graff-Radford, Jonathan, Jones, David T., Schwarz, Christopher G., Gunter, Jeffrey L., Senjem, Matthew L., Rocca, Walter A., Petersen, Ronald C.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2019
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6632154/
https://ncbi.nlm.nih.gov/pubmed/31305929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2019.1971
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars